WEST PATERSON, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. , a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the fourth quarter and fiscal-year 2005 ended September 30, 2005 on Monday December 12, 2005. The Company will discuss these results in a conference call scheduled for 11:00 a.m. ET on December 12, 2005.
Interested parties can access the call by dialing (877) 407-9205 or (201) 689-8054 or by accessing the web cast at http://www.tutogen.com/investor.asp. A replay of the call will be available at (877) 660-6853 or (201) 612-7415, account number 286 and access number 180042 for 7 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.asp for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and Germany. For more information, visit the Company's Web site at http://www.tutogen.com.
Contacts: George Lombardi, Chief Financial Officer The RCG Group Tutogen Medical, Inc. Institutional: Joe Diaz 973-785-0004, ext. 101 Retail: Joe Dorame glombardi@tutogen.com 602-889-9700
Tutogen Medical, Inc.CONTACT: George Lombardi, Chief Financial Officer of Tutogen Medical,Inc., +1-973-785-0004, ext. 101, glombardi@tutogen.com; or Institutional,Joe Diaz, or Retail, Joe Dorame, both of The RCG Group, +1-602-889-9700,for Tutogen Medical, Inc.
